Manufacturing news briefs – stories you might have missed

LBT Innovations extends analysis device uses

Medical device manufacturer LBT Innovations has applied to the US Food and Drug Administration to extend the approved use of its APAS laboratory device which uses artificial intelligence to automate microbiology laboratory tests. The Adelaide company is seeking to add detection of
Methicillin-resistant Staphylococcus aureus (MRSA) bacteria to APAS’s capabilities. The instrument’s MRSA module is already approved in Australia and Europe.

Over-reliance on imported goods acknowledged by COVID-19 coordination boss

Former Fortescue Metals CEO Nev Power, now heading the COVID-19 Coordination Commission, has commented on Australian dependence on low-cost manufacturing hubs in Asia and the possibility of reshoring supply chains disrupted by the pandemic. He told a 6PR radio host last week that there’s “an opportunity that we can take out of this crisis to change that and put in new investment, new technologies, take advantage of our low dollar.”

Amaero International continues metal additive manufacturing

3D printing group Amaero International’s operations here and in the United States are considered essential services by their respective governments and are continuing their operations during the Covid-19 pandemic. The company produces defence related components in El Segundo, Los Angeles and its’ recently-opened Adelaide facility.

EdenCrete in large US order

Carbon fibre concrete additive company EdenCrete has received a US$120,000 order in the United States which furthers its claims of improving the performance characteristics of concrete, in this case a heavy duty, high wear slab for a major industrial facility. The contractor, who won a tender against competition from metal fibre reinforced alternatives, was able to reduce the thickness of the slab by 7.5 per cent while maintaining performance.

Picture: Amaero International

Subscribe to our free @AuManufacturing newsletter here.